Glutamate Efflux across the Blood–Brain Barrier: New Perspectives on the Relationship between Depression and the Glutamatergic System

Depression is a significant cause of disability and affects millions worldwide; however, antidepressant therapies often fail or are inadequate. Current medications for treating major depressive disorder can take weeks or months to reach efficacy, have troubling side effects, and are limited in their...

Descripción completa

Detalles Bibliográficos
Autores principales: Gruenbaum, Benjamin Fredrick, Zlotnik, Alexander, Frenkel, Amit, Fleidervish, Ilya, Boyko, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143347/
https://www.ncbi.nlm.nih.gov/pubmed/35629963
http://dx.doi.org/10.3390/metabo12050459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143347/
https://www.ncbi.nlm.nih.gov/pubmed/35629963
http://dx.doi.org/10.3390/metabo12050459

Ejemplares similares